Wednesday, December 14, 2022 12:28:37 PM
Pursuant to the terms and conditions of the Asset Purchase Agreement, the Company
sold the Probiotic Business to the Purchaser effective November 21, 2022. As
consideration for the acquisition of the Probiotic Business, the Purchaser paid the
Company US$4,000,000 in cash on closing of the transaction and will pay an additional
US$1,000,000 in cash on December 31, 2022, subject to adjustment in certain
circumstances. Pursuant to the Asset Purchase Agreement, the Purchaser has also
assumed certain outstanding liabilities of the Company.
The Company anticipates using a portion of the cash proceeds to complete its financial
audits.
A copy of the Asset Purchase Agreement is available under the Company’s SEDAR profile
at www.sedar.com
They call me Lazarous!
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM